Safety Study of Autologous Umbilical Cord Blood Cells for Treatment of Hypoplastic Left Heart Syndrome

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 15, 2013

Primary Completion Date

April 28, 2021

Study Completion Date

April 28, 2021

Conditions
Hypoplastic Left Heart Syndrome
Interventions
BIOLOGICAL

autologous cell-based delivery

"autologous cells (derived from self)"

Trial Locations (6)

19104

Children's Hospital of Philadelphia, Philadelphia

55404

Children's Hospital of Minnesota, Minneapolis

55905

Mayo Clinic, Rochester

73104

Oklahoma University Children's Hospital, Oklahoma City

80045

Children's Hospital Colorado, Aurora

90027

Children's Hospital Los Angeles, Los Angeles

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

University of Oklahoma

OTHER

collaborator

Children's Hospital of Philadelphia

OTHER

collaborator

Children's Hospitals and Clinics of Minnesota

OTHER

collaborator

Children's Hospital Los Angeles

OTHER

collaborator

Children's Hospital Colorado

OTHER

collaborator

Mayo Clinic

OTHER

lead

Timothy J Nelson, MD, PhD

OTHER

NCT01883076 - Safety Study of Autologous Umbilical Cord Blood Cells for Treatment of Hypoplastic Left Heart Syndrome | Biotech Hunter | Biotech Hunter